1. Adem, A., Nordberg, A., Bucht, G., and Winblad, B. (1986). Nicotinic and muscarinic binding sites on lymphocytes from Alzheimer patients. In Fisher, A., Hanin, I., and Lachman, C. (eds.),Alzheimer's and Parkinson's Disease: Strategies for Research and Development, Plenum Press, New York, pp. 337–344.
2. Aquilonius, S. (1989). Parkinson's disease-etiology and smoking.Prog. Brain Res. 79:329–333.
3. Araujo, D. M., Lapchak, P. A., Collier, B., and Quirion, R. (1989). N-[3H]Methylcarbamylcholine binding sites in the rat and human brain: Relationship to functional nicotinic autoreceptors and alterations in Alzheimer's disease.Prog. Brain Res. 79:345–352.
4. Arneric, S. P., Sullivan, J. P., and Williams, M. (1995). Neuronal nicotinic acetylcholine receptors-novel targets for CNS therapeutics. In Bloom, F. E., and Kupfer, D. J. (eds.),Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York.
5. Ashton, H., Marsh, V., Millman, J., Rawlins, M., Stepney, R., Telford, R., and Thompson, J. W. (1979). Patterns of behavioral, autonomic, and electrophysiological response to cigarette smoking and nicotine in man. In Remond, A., and Izard, C. (eds.),Electrophysiological Effects of Nicotine, Elsevier, New York.